Molecular Testing Lab (CLIA Lab)
Molecular Testing Lab (MTL) provides services to meet the medical
needs of the University of Michigan Health System and the clients of the
M-Labs outreach program in the Department of Pathology. The laboratory
was founded by Dr. Chinnaiyan. The Clinical Director of the lab is Dr.
Lakshimi Kunju who is board-certified in Anatomical and Clinical
Pathology. The lab is fully accredited by Clinical Laboratory
Improvement Amendment (Accreditation # 23D1088637) and College of
American Pathologists (Accreditation # 7213473) and active in the CAP
Laboratory Accreditation and Proficiency Testing programs. The Technical
Director of the MCTP CLIA laboratory is Javed Siddiqui, M.S. and
support staff includes 4 certified medical technologists. Currently, MTL
offers urine PCA3 (Gen-Probe) test for prostate cancer detection and
CellSearch® Circulating Tumor Cell (CTC) testing for breast, prostate
and colorectal cancers and the recently developed Mi Prostate Score (MiPS) test.To order these test, click here.
The MCTP CLIA lab is also developing clinical tests for the detection of cancer gene fusions in patient tissues using automated FISH and immunohistochemistry (IHC) staining methods. We are working with Gen-Probe Inc., which has licensed the technology, to develop the assay designed to detect the gene fusion TMPRSS2:ERG for clinical use and we hope to offer the test to patients in the near future. Other assays in early development are novel Immunohistochemistry-based automated methods for the simultaneous assessment of ERG/ PTEN and ERG/SPINK1 status in prostate cancer for clinical use.
Click here for more information on available tests and information on how to order tests or call: (734) 232-0834.
For more information on tests offered through MLabs, please visit: University of Michigan MLabs